Latest Articles
- Selecting antithrombotic therapy for patients with atrial fibrillation
When considering anticoagulant therapy for patients with atrial fibrillation, one must balance the reduction in risk of thromboembolism that this therapy offers against the risk of bleeding that it poses. The American Heart Association, American College of Cardiology, and Heart Rhythm Society updated their atrial fibrillation guidelines in 2014. This review outlines a rationale for clinical decision-making based on the new guidelines and summarizes the currently approved drugs.
- When does an adult with headaches need central nervous system imaging?
Without red-flag symptoms, central nervous system imaging is unwarranted and may be harmful.
- Identifying statin-associated autoimmune necrotizing myopathy
Unlike simple myalgia or myositis, this condition can persist or even arise de novo after the statin is stopped.
- Updated guidelines on cardiovascular evaluation before noncardiac surgery: A view from the trenches
The purpose is not to get clearance for surgery but to evaluate the patient’s medical status and risk of complications.
- Ebola virus: Questions, answers, and more questions
The clinical virology of Ebola virus, the reported proposed treatments, and an overview of the current outbreak.
- Syncope: Etiology and diagnostic approach
There are three major types: neurally mediated, orthostatic, and cardiac. The goal is to rule out structural heart disease.